It may not seem like a big deal but the lack of a clear, operationalized definition of agitation associated with dementia was, until relatively recently, one of the barriers to getting FDA approval for any treatment for it. This is why the development of the International Psychogeriatric Association criteria for agitation associated with dementia (Sano…